Follow the people · Insider
Erin Pennock Foff
Erin Pennock Foff files insider transactions with the SEC as a chief medical officer of MapLight Therapeutics (MPLT). We hold 9 disclosed purchases and sales filed since 28 October 2025, 3 of them in the last 90 days.
- Files forMPLT
- Disclosed buys and sells9 in all, 3 in the last 90 days
- Last disclosure19 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 October 2025 — 17 August 2026Chief Medical Officer · MapLight Therapeutics (MPLT)32 Form 4 lines · source: SEC Form 4
Everything they disclosed
32 entries, newest first — one per disclosure report, one per Form 4 line- was granted 13,360 shares of MapLight TherapeuticsSEC Form 419 August 2026Voting Common Stock · traded 17 August 2026 · filed 19 August 2026
- was granted 54,240 shares of MapLight Therapeutics (a derivative holding)SEC Form 419 August 2026Employee Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 7,155 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 7,845 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 4,465 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 8,972 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 18 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 9,163 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 5,865 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 19 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 3,656 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 17 July 2026 · filed 17 July 2026
- ▼ sold on the open market 4,321 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 7 May 2026 · filed 11 May 2026
- ▼ sold on the open market 117 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 7 May 2026 · filed 11 May 2026
- ▼ sold on the open market 9,180 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 5,460 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 312 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 700 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 9,645 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 5 May 2026 · filed 6 May 2026
- ▼ sold on the open market 931 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 5 May 2026 · filed 6 May 2026
- ▼ sold on the open market 8,152 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 6 May 2026 · filed 6 May 2026
- ▼ sold on the open market 15,900 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 6 May 2026 · filed 6 May 2026
- ▼ sold on the open market 2,044 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 288 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 16 April 2026 · filed 17 April 2026
- ▼ sold on the open market 881 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 16 April 2026 · filed 17 April 2026
- was granted 13,360 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- was granted 54,240 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 54,240 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 13,360 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- had shares withheld for tax on 44,616 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- had shares withheld for tax on 44,616 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- was granted 196,035 shares of MapLight Therapeutics (a derivative holding)SEC Form 428 October 2025Employee Stock Option (right to buy) · traded 27 October 2025 · filed 28 October 2025
- was granted 48,275 shares of MapLight TherapeuticsSEC Form 428 October 2025Voting Common Stock · traded 27 October 2025 · filed 28 October 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.